RIGHTS AND ISSUES INVESTMENT TRUST PLC
At the 31st December 2014 the unaudited net asset value of the shares in Rights
and Issues Investment Trust Plc were:
25p Capital Shares 5188.4p (5529.9p at the 31st December 2013)
25p Income Shares 1263.6p (1334.0p at the 31st December 2013)
The following list represents the Trust's ten largest investments and where
appropriate, any investment with a value greater than 5% of the Trust's gross
assets:
Class Value £ Holding greater than 5% of Gross
Assets
Scapa Group Ordinary 13,787,063 Yes
VP Ordinary 11,160,000 Yes
Brammer plc Ord Ordinary 9,173,250 Yes
RPC Group Ordinary 9,001,416 Yes
Hill & Smith Holdings Ordinary 8,289,849 Yes
Treatt Ordinary 7,854,000 Yes
Colefax Group Ordinary 7,380,000 Yes
Macfarlane Group Ordinary 5,877,306 Yes
British Polythene Ind Ordinary 5,010,150 No
Renold Ordinary 4,833,600 No
The above information is as at 31st December 2014.
Submitted on behalf of Rights and Issues Investment Trust plc by:
George Bayer
Phoenix Administration Services Limited
Telephone: 01245 398984
6th February 2014
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.